Literature DB >> 30218652

Immunological responsiveness of intestinal tissue explants and mucosal mononuclear cells to ex vivo stimulation.

Rhonda M Brand1, Nabanita Biswas2, Aaron Siegel3, Ashley Myerski3, Jarret Engstrom3, E Jeffrey Metter4, Randall E Brand2, Ross D Cranston2, Ian McGowan5.   

Abstract

BACKGROUND: There are limited data on the immunological responsiveness of healthy intestinal tissue when it is cultured and stimulated ex vivo. Such an ex vivo model has the potential to be a valuable tool in understanding disease pathogenesis and as a preclinical tool for the assessment of candidate therapeutic agents used to treat inflammatory bowel disease (IBD). AIM: We undertook a comprehensive study to evaluate ex vivo immunological responses of intestinal tissue and isolated mucosal mononuclear cells (MMC) to a broad range of stimuli.
METHODS: Colorectal biopsies (explants) were obtained from healthy participants by flexible sigmoidoscopy and were placed either directly into culture or digested to isolate MMC prior to placement in culture. Explants or MMC were treated with polyinosinic:polycytidylic acid (Poly IC), phytohemagglutinin (PHA), lipopolysacccharides from E Coli (LPS), anti-CD3/CD28 antibodies, or IL-1β/TNF-α for 24 h. Supernatants were assayed for 40 inflammatory biomarkers using multiplexed enzyme-linked immunosorbent assay (ELISA). The isolated MMCs were further characterized using twelve color flow cytometry.
RESULTS: Explants have greater weight adjusted constitutive expression of inflammatory biomarkers than MMCs. Biomarker responses varied as a function of immunogen and use of intact tissue or isolated cells. PHA applied to intact explants was the most effective agent in inducing biomarker changes. Stimulation induced activated and memory cellular phenotypes in both explants and MMCs.
CONCLUSIONS: The breadth and magnitude of responses from intact and enzymatically digested intestinal tissue explants stimulated with exogenous immunogens are complex and vary by tissue form and treatment. Overall, PHA stimulation of intact explants produced the most robust responses in normal human colorectal tissue. This system could potentially serve as a preliminary model of the disease state, suitable for small scale screening of new therapeutic agents prior to using IBD patient derived tissue.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Biopsy; Colorectal; Immunogen; Phenotype

Mesh:

Substances:

Year:  2018        PMID: 30218652     DOI: 10.1016/j.jim.2018.08.009

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells.

Authors:  Rhonda M Brand; Beverley A Moore; Ashley Zyhowski; Aaron Siegel; Shikhar Uttam; E Jeffrey Metter; Jarret Engstrom; Randall E Brand; Nabanita Biswas; David C Whitcomb; David G Binion; Marc Schwartz; Ian McGowan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-12-23       Impact factor: 4.052

2.  Early Colorectal Responses to HIV-1 and Modulation by Antiretroviral Drugs.

Authors:  Carolina Herrera; Mike D McRaven; Ken G Laing; Jayne Dennis; Thomas J Hope; Robin J Shattock
Journal:  Vaccines (Basel)       Date:  2021-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.